Alaunos Therapeutics

About:

Alaunos Therapeutics is a biotechnology company that acquires, develops, and commercializes cancer therapies.

Website: https://alaunos.com/

Twitter/X: ZIOPHARM

Top Investors: Essex Woodlands Healthcare Partners, Emerging Technology Partners, Henderson Global Investors, Cycad Group, Paramount BioCapital Asset Management

Description:

Alaunos Therapeutics is a biotechnology company employing a novel gene expression and control technology to deliver DNA for the treatment of cancer. ZIOPHARM's technology platform employs Intrexon Corporation's RheoSwitch Therapeutic System® to turn on and off and precisely modulate gene expression at the cancer site in order to improve the therapeutic index. This technology is currently being evaluated in Phase 2 clinical studies of the immune system cytokine interleukin-12 for the treatment of breast cancer and advanced melanoma. Multiple new INDs for new targets using similar technology are expected in 2014 and 2015. ZIOPHARM is also developing novel small molecules as potential cancer therapeutics.